Actively Recruiting

Age: 21Years +
All Genders
NCT04675138

Development of a Clinical Decision Support System With Artificial Intelligence for Cancer Care

Led by National University Hospital, Singapore · Updated on 2024-10-10

1000

Participants Needed

9

Research Sites

227 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Clinical Decision Support Systems (CDSSs) to augment clinical care and decision making. These are platforms which aim to improve healthcare delivery by enhancing medical decisions with targeted clinical knowledge, patient information, and other health information. In view of the benefit of developing a CDSS, we sought to develop an alternative CDSS for oncologic therapy selection through a partnership with Ping An Technology (Shenzhen, China), beginning with gastric and oesophagal cancer. This would be done in a piecemeal fashion, with the prototype platform utilizing only international guidelines and high-quality published evidence from journals to arrive at case-specific treatment recommendations. This platform would then be evaluated by comparing its recommendations with that from the multidisciplinary tumour boards of several tertiary care institutions to determine the concordance rate.

CONDITIONS

Official Title

Development of a Clinical Decision Support System With Artificial Intelligence for Cancer Care

Who Can Participate

Age: 21Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with primary gastric adenocarcinoma including preinvasive carcinoma
  • Patients with gastroesophageal junction cancers
  • Patients with esophageal cancer including adenocarcinoma, squamous cell carcinoma, and preinvasive carcinoma subtypes
  • Patients with esophageal or gastroesophageal junction adenocarcinoma (for prospective validation part)
Not Eligible

You will not qualify if you...

  • Patients with other primary cancers involving the stomach or esophagus
  • Patients with other cancer subtypes
  • Patients with concomitant cancers of other organs
  • Patients with esophageal squamous cell carcinoma (for prospective validation part)
  • Patients participating in clinical trials where the treatment is not standard of care

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

University Hospital Leipzig

Leipzig, Germany

Actively Recruiting

2

National Cancer Centre Hospital East

Kashiwa, Japan

Actively Recruiting

3

National University Hospital

Singapore, Singapore, 119228

Actively Recruiting

4

National Cancer Centre Singapore

Singapore, Singapore

Actively Recruiting

5

Ng Teng Feng General Hospital

Singapore, Singapore

Actively Recruiting

6

Tan Tock Seng Hospital

Singapore, Singapore

Actively Recruiting

7

Seoul National University Hospital

Seoul, South Korea

Actively Recruiting

8

Karolinska Institute Hospital

Stockholm, Sweden

Actively Recruiting

9

The University of Edinburgh

Edinburgh, United Kingdom

Actively Recruiting

Loading map...

Research Team

B

Bok Yan, Jimmy So

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here